High dose rate afterloading 192 iridium prostate brachytherapy

Since the evolution of prostate-specific antigen testing for prostate cancer, men have been diagnosed with earlier staged disease. Earlier staged cancer is amenable to local therapy. Over the last decade, new technology has evolved in the treatment of localized prostate cancer. High dose rate afterloading 192 Iridium prostate brachytherapy is a new innovative technique utilizing state of the art equipment and highly specialized computers to achieve precise treatment of prostate cancer with radiation. We present our initial experience with this innovative technique.